tradingkey.logo

Aclarion Inc

ACONW

0.028USD

+0.001+5.24%
Market hours ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Aclarion Inc

0.028

+0.001+5.24%
More Details of Aclarion Inc Company
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Company Info
Ticker SymbolACONW
Company nameAclarion Inc
IPO dateApr 22, 2022
CEOMr. Brent Ness
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address8181 Arista Place
CityBROOMFIELD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80021
Phone18332752266
Websitehttps://aclarion.com/
Ticker SymbolACONW
IPO dateApr 22, 2022
CEOMr. Brent Ness
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. John Lorbiecki
Mr. John Lorbiecki
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. John Lorbiecki
Mr. John Lorbiecki
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Feb 23
Updated: Sun, Feb 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
9
413.13K
0.00%
-140.13K
2025Q1
9
413.13K
0.00%
-140.13K
2024Q4
9
486.12K
0.00%
-63.53K
2024Q3
9
482.41K
0.00%
-31.05K
2024Q2
10
556.22K
0.00%
-87.15K
2024Q1
10
731.36K
0.00%
-438.75K
2023Q4
10
1.26M
0.00%
+65.32K
2023Q3
10
1.17M
0.00%
-14.90K
2023Q2
10
1.17M
0.00%
+192.71K
2023Q1
8
975.13K
0.00%
+100.42K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Worth Venture Partners, LLC
286.28K
0%
+107.86K
+60.45%
Dec 31, 2023
CAPTRUST Financial Advisors
78.40K
0%
--
--
Mar 31, 2025
Clear Street LLC
47.12K
0%
+310.00
+0.66%
Mar 31, 2025
Citadel Advisors LLC
--
0%
-40.00K
-100.00%
Mar 31, 2025
Armistice Capital LLC
--
0%
-34.38K
-100.00%
Mar 31, 2025
UBS Financial Services, Inc.
1.09K
0%
+837.00
+324.42%
Mar 31, 2025
Warberg Asset Management LLC
--
0%
-15.00K
-100.00%
Jun 30, 2024
Hudson Bay Capital Management LP
--
0%
-160.00K
-100.00%
Jun 30, 2024
BofA Global Research (US)
237.00
0%
+237.00
--
Mar 31, 2025
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI